Chembion Seminar

Overview of guests invited by the RTG Chembion

 
Date Name Affiliation Title
2022      

31.05.2022

combined PharmaCampus Kolloquium and Chembion Seminar

Prof. Dr. Laura Mercolini University of Bologna - Department of Pharmacy and Biotechnology (FaBiT) “Methods to quantify drugs in biological fluids from small sample volumes.”

24.05.2022

combined PharmaCampus Kolloquium and Chembion Seminar

Dr. Michael Schulte Merck KGaA „390 Jahre Chinin - die lange Karriere eines besonderen Arzneistoffes“
19.05.2022 Prof. Dr. Dr. Dr. Sven Meuth

Klinik für Neurologie

Universitätsklinikum Düsseldorf

'Ion modulation in MS'
17.03.2022 Prof. Dr. Petra Dersch Institut für Infektiologie, WWU Münster 'Structural-functional analysis of crucial virulence factors of Yersinia.'
23.02.2022

Dr. Annika Lüttjohann

Institute for Physiology I, WWU Münster

'Generation and generalization mechanisms of absence seizures.'

08.02.2022 3rd Chembion Symposium

Prof. Dr. Dario DiFrancesco

Università degli Studi di Milano

'Funny current/HCN channels in health and disease: a 40-year journey'

08.02.2022 3rd Chembion Symposium

Prof. Dr. Ivana Novak

Section for Cell Biology and Physiology, Department of Biology, University of Copenhagen, Denmark

'Purinergic signaling in pancreas - in health and disease'

08.02.2022 3rd Chembion Symposium

Associate Prof. Dr. Alessandra Fiorio Pla Department of Life Science and Systems Biology, and Nanostructured Interfaces and Surfaces Centre of Excellence (NIS), University of Torino, Italy 'TRPM8-Rap1 interaction plays a key protective role in angiogenesis and cancer cells migration'

08.02.2022 3rd Chembion Symposium

Prof. Dr. Patrik Rorsman

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, UK

'Causes and treatment of diabetes: role of ion channels'

02.02.2022 Dr. Maren Lindner Klinik für Neurologie mit Institut für Translationale Neurologie
Uniklinikum Münster
'The underestimated role of T cells in neuromyelitis optica (NMO).'
26.01.2022 PD Dr. Stjepana Kovac Klinik für Neurologie mit Institut für Trans-lationale Neurologie
Uniklinikum Münster
'Reactive oxygen species and hyperexcitability.'
2021      
15.12.2021 Prof. Dr. Justin Du Bois Department of Chemistry, Stanford University, USA 'Using Chemistry to Study Voltage-Gated Sodium Channels.'
17.11.2021 Prof. Dr. Alistair Mathie Medway School of Pharmacy
The Universities of Greenwich and Kent at Medway, UK
'Pharmacological approaches to studying potassium channels.'
27.10.2021 Prof. Dr. Stefan Huber Universitätsklinik für Radioonkologie
Universitätsklinikum Tübingen
'Neuro-oncology of IK and BK Calcium-Activated Potassium Channels'
01.09.2021 Dr. Ahmed Haider Harvard Medical School, Massachusetts General Hospital, Department of Radiology, Boston, USA 'Subtype-Selective NMDA Receptor Imaging with Positron Emission Tomography – From Molecular Concepts to Precision Medicine.'
30.06.2021 Prof. Dr. Michael Ziller Lab for Functional Genomics in Psychiatry, WWU Münster 'Dissecting the polygenic basis of schizophrenia using pluripotent stem cells and functional genomics.'
23.06.2021 Asst. Prof. Dr. Matthew Eddy Chemistry – Chemical Biology Division, University of Florida 'Mechanisms of Allosteric Modulation of Human GPCRs by Small Molecules and Cellular Lipids'
16.06.2021 Prof. Dr. Bryan Roth Department of Pharmacology, Eshelman School of Medicine, University of North Carolina at Chapel Hill

'Structure-guided GPCR drug discovery'

05.05.2021 Dr. Kenneth A. Jacobson Laboratory of Bioorganic Chemistry
National Institute of Diabetes and Digestive and Kidney Diseases
Bethesda, USA
'Design and therapeutic potential of purinergic receptor ligands.'
21.04.2021 PD Dr. Ursula Storch Walther-Straub-Institut für Pharmakologie und Toxikologie / IPEK
Ludwig-Maximilians-Universität München
'Molecular insights into receptor-operated TRPC channel activation'
07.04.2021 Prof. Dr. Alan Kay University of Iowa, Department of Biology, Iowa City, USA 'Why K+?'
03.03.2021 Prof. Dr. Patrick Bednarski Pharmaceutical/Medicinal Chemistry, University of Greifswald, Greifswald 'Pentathiepins: New anticancer agents?'
17.02.2021 Prof. Dr. Christos Gatsogiannis Centre for Theoretical Medicine, Institute for Medical Physics and Biophysics, WWU Münster 'Structural Biology in the era of cryoEM.'

09.02.2021 2nd Chembion Symposium

Prof. Dr. Daniel Minor University of California, USA 'K2P Channel Gating - Caught in the Act'
09.02.2021 2nd Chembion Symposium Prof. Dr. John White Boston University, USA 'Engineering Approaches to Understand Functional Connectivity in Neocortex'
09.02.2021 2nd Chembion Symposium Prof. Dr. Ildikò Szabò University of Padova, Italy 'Mitochondrial Ion Channel in Cancer'
09.02.2021 2nd Chembion Symposium Dr. Pierre Paoletti Institut de Biologie de l'École Normale Supérieure, Paris, France 'Illuminating NMDA receptor structure and function using molecular optogenetics'
03.02.2021 Prof. Dr. Luis A. Pardo Max-Planck-Institute of Experimental Medicine, Göttingen 'Targeting the voltage-gated potassium channel KV10.1 for cancer therapy?'
2020      
08.12.2020 Prof. Dr. Eric Beitz Christian-Albrechts-Universität Kiel 'Novel anti-malarial compounds inhibit the parasite's lactate/H+ transporter.'
25.11.2020 Dr. Felix Neumaier Forschungszentrum Jülich 'Role of Zn2+ and Cu2+ in the central nervous system.'
24.11.2020 Prof. Dr. Heike Wulff University of California, Davis, USA 'KCa3.1 ion channel, an overview of blockers and activators.'
28.10.2020 Assoc. Prof. Dr. V'yacheslav Lehen'kyi Université de Lille, France 'TRPV6 calcium channel as a prospective pharmacological target in cancer'

30.09.2020 1st Chembion Retreat

Dr. Reinhard Seifert Forschungszentrum caesar, Bonn 'Even funnier: Hyperpolarization-activated channels selective for protons'

30.09.2020 1st Chembion Retreat

Prof. Dr. Tanja Kuhlmann WWU Münster ‘How to wrap the myelin: What can we learn from stem cells?'

29.09.2020 1st Chembion Retreat

Prof. Dr. Eric Gouaux Vollum Institute, Portland, USA 'How ionotropic glutamate receptors work'

29.09.2020 1st Chembion Retreat

Prof. Dr. Daniel Kümmel WWU Münster ‘Peptide inhibitors of the α-cobratoxin/nicotinic acetylcholine receptor interaction’
16.09.2020 Prof. Dr. Evan Miller University of California, Berkeley, USA 'Electrophysiology, Unplugged: New Chemical Tools to Visualize Cellular Physiology'
31.08.2020 Prof. Dr. Christina Chai National University of Singapore, Singapore ‘Harnessing the power of natural products: Andrographolide as lead compound in the development of anti-inflamatory agents.’
22.07.2020 Prof. Dr. Dr. h.c. Herbert Waldmann Max Planck Institute of Molecular Physiology, Dortmund 'Pseudo Natural Products - Chemical Evolution of Natural Product Structure.'
01.07.2020 Prof. Dr. Yasushi Okamura Osaka University, Japan 'Where PIs are located will matter: Voltage sensing phosphatase regulates subcellular distribution of phosphoinositides in sperm membrane to regulate sperm motility.'
05.06.2020 1st Chembion Symposium Prof. Dr. Annarosa Arcangeli University of Firenze, Italy 'Targeting hERG1 channels for a therapeutic approach to cancer'
05.06.2020 1st Chembion Symposium Prof. Dr. Giuseppe Melacini McMaster University, Canada 'Mechanisms for HCN gating'
26.02.2020 Prof. Dr. Boris Musset Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg ‘Structure and function of voltage-gated proton channels.’
27.01.2020 Prof. Dr. Martin Biel Ludwig-Maximilians-Universität München 'Ion channels: from molecules to bedside'
2019      
04.12.2019 Prof. Dr. Arnd Baumann Forschungszentrum Jülich 'Role of HCN channels in hippocampal neurons.'
20.11.2019 Prof. Dr. Bodo Laube Technische Universität Darmstadt 'NMDA receptor mediated signaling in health and disease.'
07.11.2019 Dr. Jennifer Hughes University of Illinois at Urbana-Champaign, USA 'Illuminating the Sperm-Oviduct Reservoir: Use of flow cytomerty, multiphotonic and superresolution imaging in the porcine model.'